Levels of netrin receptors and netrin G2 are regulated by psychostimulant drugs (Yetnikoff et al., 2007; Argento et al., 2012), endocannabinoid receptor antagonists (Argaw et al., 2011), and epilepsy-induced activity (Pan et al., 2010). Here, NTNG2 is linked to epilepsy.